Dr. Middaugh’s research efforts involve understanding the stability limits of biopharmaceuticals and vaccines. He is a distinguished professor at the University of Kansas School of Pharmacy and currently serves as a SAB member at Takeda Vaccines VitriVax.
This person is not in the org chart